TREA

85872878 - NEUROPRO

Follow

Information

  • Trademark
  • 85872878
  • Serial Number
    85872878
  • Filing Date
    March 11, 2013
    11 years ago
  • Transaction Date
    December 02, 2014
    10 years ago
  • Status Date
    November 25, 2014
    10 years ago
  • Location Date
    December 02, 2014
    10 years ago
  • Status Code
    603
  • Current Location
    TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    PHILLIPS, WENDELL SHAR
  • Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NEUROPRO
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0051: Herbal supplements containing ginseng and ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; medical food supplements in powdered, liquid and tablet form for the prevention and treatment of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis; medical food for the treatment of spinal cord injury and brain injury; medical food supplements in powdered, liquid and tablet form; medical food supplements in powdered, liquid and tablet form for use in the dietary management of patients with neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury; ginseng, ginsenocides and omega-3 fatty acids for the dietary management of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury
  • PM0000: NEURO PRO; NEUROLOGICAL PRO
Case File Event Statements
  • 12/2/2014 - 10 years ago
    30 - ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Type: MAB3
  • 11/25/2014 - 10 years ago
    29 - ABANDONMENT - AFTER EX PARTE APPEAL Type: ABN3
  • 11/25/2014 - 10 years ago
    28 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 10/16/2014 - 10 years ago
    27 - EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF Type: EXFB
  • 7/22/2014 - 10 years ago
    26 - NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Type: GEA1
  • 7/22/2014 - 10 years ago
    25 - ACTION DENYING REQ FOR RECON E-MAILED Type: GECD
  • 7/22/2014 - 10 years ago
    24 - ACTION CONTINUING FINAL - COMPLETED Type: CNCF
  • 7/15/2014 - 10 years ago
    23 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 7/10/2014 - 10 years ago
    22 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 7/15/2014 - 10 years ago
    21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/14/2014 - 10 years ago
    20 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 7/14/2014 - 10 years ago
    19 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 7/14/2014 - 10 years ago
    18 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 7/11/2014 - 10 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/10/2014 - 10 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/10/2014 - 10 years ago
    15 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 7/10/2014 - 10 years ago
    14 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 1/14/2014 - 11 years ago
    13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/14/2014 - 11 years ago
    12 - FINAL REFUSAL E-MAILED Type: GNFR
  • 1/14/2014 - 11 years ago
    11 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/24/2013 - 11 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/23/2013 - 11 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/23/2013 - 11 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/24/2013 - 11 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/24/2013 - 11 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/24/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/20/2013 - 11 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2013 - 11 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 3/15/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/14/2013 - 11 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP